Asenapine (Saphris) Manufacturing Plant Project Report 2025
Introduction The Asenapine (Saphris) Manufacturing Plant Project Report provides an in-depth analysis and roadmap for setting up a manufacturing facility dedicated to the production of Asenapine, a second-generation atypical antipsychotic drug, sold under the brand name Saphris. Asenapine is used for the treatment of schizophrenia and bipolar disorder, primarily in adult patients. The increasing demand…